Guest Post: Denmark’s pilot pharma trial attracts first-movers

Denmark’s pilot pharma trial attracts first-movers By Arundati Dandapani Europe is open for business, and Denmark wants to be the first-mover. Europe, forecasted to be the world’s biggest legal cannabis market by 2024 will exceed North America, the dominant market today, according to Prohibition Partners. Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament.   Denmark’s program was aimed at improving access to patients in need of cannabis, initially for those suffering from multiple sclerosis and nausea after chemotherapy, and later paraplegics and pain patients. “Ever since expanding the patient groups, we were not able to import enough cannabis,” stated Jane Heitmann, Danish Liberal party MP at the recent Cannabis Europa Conference’s Transatlantic Forum in Toronto. “We gave the option to foreign companies to cultivate in Denmark.”   Denmark was among the first countries to allow big-scale cannabis production with 34 companies licenced to grow and handle medical cannabis, attracting the highest foreign investment in Europe to build out medical cannabis cultivation and productions (worth $400 million). Heitmann admitted there were challenges connected to being the first-mover in Big Pharma. She said, “We looked…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Guest Post: Denmark’s pilot pharma trial attracts first-movers
reposted by Cannabis News World